Hedge Fund - Opaleye Management
Eton Pharmaceuticals Inc. (ETON)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q4 (2024-12-31) | $37,989,572 | 6.64% | 2,852,070 | $10.14 |
2 | 2024 - Q3 (2024-09-30) | $16,680,000 | 2.78% | 2,780,000 | $4.23 |
3 | 2024 - Q2 (2024-06-30) | $7,879,550 | 1.8% | 2,395,000 | $3.50 |
4 | 2024 - Q1 (2024-03-31) | $9,171,679 | 1.99% | 2,445,781 | $4.37 |
5 | 2023 - Q4 (2023-12-31) | $11,080,905 | 2.94% | 2,529,887 | $4.01 |
6 | 2023 - Q3 (2023-09-30) | $10,134,226 | 3.29% | 2,430,270 | $3.86 |
7 | 2023 - Q2 (2023-06-30) | $7,974,650 | 1.9% | 2,285,000 | $3.68 |
8 | 2023 - Q1 (2023-03-31) | $8,412,250 | 2.51% | 2,185,000 | $3.65 |
9 | 2022 - Q4 (2022-12-31) | $6,119,400 | 2.12% | 2,170,000 | $2.69 |
10 | 2022 - Q3 (2022-09-30) | $5,294,000 | 2.18% | 2,521,000 | $2.49 |
11 | 2022 - Q2 (2022-06-30) | $6,452,000 | 2.9% | 2,462,500 | $3.36 |
12 | 2022 - Q1 (2022-03-31) | $10,374,000 | 3.22% | 2,379,275 | $3.93 |
13 | 2021 - Q4 (2021-12-31) | $10,232,000 | 2.17% | 2,385,000 | $4.78 |
14 | 2021 - Q3 (2021-09-30) | $15,564,000 | 2.9% | 3,088,100 | $5.20 |
15 | 2021 - Q2 (2021-06-30) | $29,310,000 | 4.86% | 3,692,600 | $7.41 |
16 | 2021 - Q1 (2021-03-31) | $29,573,000 | 4.34% | 4,040,000 | $8.53 |
17 | 2020 - Q4 (2020-12-31) | $32,845,000 | 4.29% | 4,040,000 | $7.71 |
18 | 2020 - Q3 (2020-09-30) | $28,756,000 | 5.62% | 3,640,000 | $6.83 |
19 | 2020 - Q2 (2020-06-30) | $19,838,000 | 4% | 3,640,000 | $4.97 |
20 | 2020 - Q1 (2020-03-31) | $14,924,000 | 3.95% | 3,640,000 | $5.84 |
21 | 2019 - Q4 (2019-12-31) | $10,580,000 | 2.07% | 1,469,456 | $6.18 |
22 | 2019 - Q3 (2019-09-30) | $7,363,000 | 2.66% | 1,165,000 | $6.38 |
23 | 2019 - Q2 (2019-06-30) | $8,493,000 | 2.58% | 1,075,000 | $7.77 |
24 | 2019 - Q1 (2019-03-31) | $6,118,000 | 1.69% | 764,773 | $6.95 |
25 | 2018 - Q4 (2018-12-31) | $3,200,000 | 1.19% | 523,000 | $6.13 |
The displayed share prices are average quarterly stock market prices.